Category: Health
Browse by:
- ServicesStrategic Partnerships & Global EngagementClimate & BiodiversityCapital MarketsChange & TransformationPublic Affairs & Government RelationsInternal Culture & EngagementCompetition and M&ASocial Impact & ESGIntegrated MediaAdvocacy CampaignsExecutive PositioningReputation & Brand ManagementResearch, Analytics and MeasurementCrisis, Issues & LitigationCreative Strategy & DesignCorporate CommunicationGeo-Commerce & Risk
- Sectors
- Regions
Disruption at HHS: Does It Have a Purpose? What Might It Be?
Significant disruptions at HHS under Secretary Robert Kennedy, Jr. are reshaping public health. Employee reductions and program cuts threaten vital services, exacerbating crises like the Texas measles outbreak and raising concerns about future responses....
Health Care's Leadership Moment: Stepping in to Fill the Gap
APCO’s latest 2025 Pulse Check survey report, which captures public perception from the presidential transition period, reveals a nuanced picture of public trust in health care institutions and information sources....
2025 Europe Outlook
As 2025 approaches, the EU faces new challenges and opportunities, focusing on a Clean Industrial Deal, AI and digital sovereignty. Explores the outlook for EU policies aimed at strengthening Europe’s prosperity in a complex global landscape....
High-Quality Data: Essential for Addressing Health Inequity in Southeast Asia
Significant progress has been made toward Sustainable Development Goal (SDG) 3, but health inequities persist, particularly in Southeast Asia. Improved disaggregated health data is essential for addressing disparities. Countries are encouraged to enhance data collection and leverage existing systems while taking actionable steps....
Profile of FDA Commissioner Nominee Martin Makary
Martin (Marty) Makary is a surgeon and public policy researcher at Johns Hopkins in Baltimore. He is also a prolific author and has been in the forefront of public commentary on the health care system for several years....
Indonesian President Prabowo Visits Beijing and Washington
Indonesia’s new President, Prabowo Subianto, visited Beijing and Washington, D.C., from November 8 to 12 before attending his first APEC Summit. Explore key takeaways and comparisons from those visits....
The Food and Drug Administration in the Trump Administration
Elections impact health and regulatory policy. This year's Trump election and new Republican majorities could affect the FDA and industries it regulates. Here are 10 key observations on these potential changes....
FemTech: Transforming Women's Health
FemTech is driving a transformation in women's health by addressing gaps in medical research, accessibility, and care for conditions uniquely impacting women. Its growth promises improved health outcomes, greater autonomy and economic benefits worldwide....
Wobbly Foundations: Starmer’s Turbulent First 100 Days
Sir Keir Starmer’s first 100 days as prime minister have been marked by internal party struggles, financial constraints and declining public support. Despite early challenges, his government is moving forward with key reforms, but the upcoming Autumn Budget will be pivotal for resetting his course....
Corporate Affairs in the Pharmaceutical Industry: How to Succeed in a Complex and Evolving Landscape
This white paper explores the evolving challenges faced by corporate affairs leaders in the pharmaceutical industry, highlighting key factors like AI, supply chain vulnerabilities, regulatory changes and the growing importance of ESG and DEI considerations....